WesBanco Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

WesBanco Bank’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,770	Closed	-$1.31M	–	600
2021 Q1	$1.31M	Buy	+2,770	New	+$1.35M	0.05%	254
2016 Q2	–	Sell	-10,426	Closed	-$3.76M	–	519
2016 Q1	$3.76M	Buy	10,426 +70	+0.7%	+$28.8K	0.22%	99
2015 Q4	$5.62M	Buy	10,356 +100	+1%	+$54.2K	0.33%	79
2015 Q3	$4.77M	Buy	10,256 +6	+0.1%	+$3.22K	0.29%	81
2015 Q2	$5.23M	Hold	10,250	–	–	0.29%	87
2015 Q1	$4.63M	Hold	10,250	–	–	0.26%	94
2014 Q4	$4.21M	Buy	10,250 +4,100	+67%	+$1.61M	0.23%	99
2014 Q3	$2.22M	Buy	+6,150	New	+$2.06M	0.12%	149

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

WesBanco Bank's REGN Position: Q2 2021 in Review

WesBanco Bank sold out of Regeneron Pharmaceuticals (REGN) in Q2 2021, closing a stake of 2,770 shares — an estimated $1.31M sold.

WesBanco Bank first reported a position in REGN in Q3 2014 and held it in 8 quarters. The position peaked at $5.62M in Q4 2015. 972 funds tracked by Wall St. Rank hold REGN as of Q2 2021.

WesBanco Bank reported no remaining Regeneron Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
WesBanco Bank sold 2,770 Regeneron Pharmaceuticals shares in Q2 2021, an estimated $1.31M.
WesBanco Bank first reported a position in Regeneron Pharmaceuticals in Q3 2014 and held it in 8 quarters.
WesBanco Bank's Regeneron Pharmaceuticals position peaked at $5.62M in Q4 2015.
972 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2021.

Based on WesBanco Bank's 13F filing for Q2 2021, filed 9 Aug 2021.